# Imaging for Significant Prostate Cancer Risk Evaluation

> **NCT01492270** · NA · UNKNOWN · sponsor: **University College London Hospitals** · enrollment: 126 (estimated)

## Conditions studied

- Prostate Cancer

## Interventions

- **PROCEDURE:** Prostate HistoScanning
- **PROCEDURE:** Multi-parametric MRI
- **PROCEDURE:** Transperineal prostate mapping biopsy
- **PROCEDURE:** Image guided biopsies

## Key facts

- **NCT ID:** NCT01492270
- **Lead sponsor:** University College London Hospitals
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2011-12
- **Primary completion:** 2013-07
- **Final completion:** 2013-07
- **Target enrollment:** 126 (ESTIMATED)
- **Last updated:** 2011-12-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01492270

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01492270, "Imaging for Significant Prostate Cancer Risk Evaluation". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01492270. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*